VeriMomhuman cord blood progenitor cell exosomes est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS/CIR safety assessment specific to 'human cord blood progenitor cell exosomes' and no published evidence of reproductive/teratogenic effects in humans or animals was identified in available regulatory sources. However, because these are biologically active extracellular vesicles carrying proteins/miRNA there is a theoretical mechanism for biological signalling (mechanism score=1). Dermal systemic exposure from topical cosmetics is expected to be low but not zero (exposure score=1) given the potential for vesicle uptake reported in topical exosome literature; no pregnancy-specific data were found.
Related ingredients
Frequently asked questions
- human cord blood progenitor cell exosomes est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS/CIR safety assessment specific to 'human cord blood progenitor cell exosomes' and no published evidence of reproductive/teratogenic effects in humans or animals was identified in available regulatory sources. However, because these are biologically active extracellular vesicles carrying proteins/miRNA there is a theoretical mechanism for biological signalling (mechanism score=1). Dermal systemic exposure from topical cosmetics is expected to be low but not zero (exposure score=1) given the potential for vesicle uptake reported in topical exosome literature; no pregnancy-specific data were found.
- human cord blood progenitor cell exosomes est-il sûr pendant l'allaitement ?
- No specific regulatory or peer‑reviewed data showing harm via breastmilk or effects on lactation. Theoretical mechanism exists (bioactive cargo could in theory be transferred systemically and into milk), but there is no empirical evidence. Dermal exposure for lactating persons is expected to be low but measurable.
- human cord blood progenitor cell exosomes est-il sûr pour la peau de bébé ?
- No data demonstrating developmental/infant toxicity from topical use. Mechanistic theoretical concern persists (bioactivity of exosome cargo). Exposure score increased by +1 for infants because immature skin has higher permeability and higher surface‑area‑to‑weight; if adult exposure is low/measurable (1), infant exposure is judged as moderate (2). No infant‑specific absorption or toxicity studies were identified.
- Comment VeriMom évalue-t-il human cord blood progenitor cell exosomes ?
- VeriMom évalue human cord blood progenitor cell exosomes à 87/100 (risque faible) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à human cord blood progenitor cell exosomes pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à human cord blood progenitor cell exosomes basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.